The montelukast sodium from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Montelukast Sodium Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The montelukast sodium market size has grown strongly in recent years. It will grow from $3.52 billion in 2023 to $3.86 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing respiratory disorders, an aging population, rising air pollution levels, growing awareness and education, and expansion in emerging markets.
The montelukast sodium market size is expected to see strong growth in the next few years. It will grow to $5.59 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to approval and launch, clinical studies, patent expiry, regulatory changes, and physician prescribing patterns. Major trends in the forecast period include increased generic competition, a shift towards combination therapies, expansion in emerging markets, a focus on pediatric use, and digital health solutions.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report
Scope Of Montelukast Sodium Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Montelukast Sodium Market Overview
Market Drivers –
The increasing prevalence of asthma is expected to propel the growth of montelukast sodium market going forward. Asthma is a chronic respiratory disorder marked by inflammation and constriction of the airways, resulting in repeated bouts of wheezing, breathlessness, chest tightness, and coughing. The prevalence of asthma is increasing due to environmental pollution, allergen exposure, genetic predisposition, urbanization, changes in lifestyle, and respiratory infections. Montelukast sodium is used in asthma as a leukotriene receptor antagonist, helping to prevent and manage asthma symptoms by blocking the action of leukotrienes, which contribute to airway inflammation and constriction. For instance, in September 2022, according to the National Health Service, a UK-based government department, hospital admissions for children with asthma in England and Wales surged by 149% between 2021 and 2022. The number of children admitted with asthma symptoms rose to 19,506, compared to 7,850 during the 2020 to 2021 period. Therefore, the increasing prevalence of asthma is driving the growth of montelukast sodium market.
Market Trends –
Major companies operating in the montelukast sodium market are developing new drugs such as fexofenadine hydrochloride and getting them approved to expand their product portfolios and address the evolving needs of patients with allergic conditions. Fexofinadine hydrochloride is a second-generation antihistamine medication approved by the FDA for treating allergy symptoms and hay fever in adults and children. For instance, in December 2021, Morepen Laboratories received approval from the US Food and Drug Administration (USFDA) to market its generic anti-allergy drug, Fexofinadine Hydrochloride, in the American market. Fexofinadine hydrochloride, a widely used second-generation antihistamine, is employed to treat allergy symptoms and hay fever. This approval signifies a significant milestone for Morepen Laboratories, strengthening its position in the anti-allergy market.
The montelukast sodium market covered in this report is segmented –
1) By Product: Crystal-like, Form-less Or Amorphous
2) By Dosage Form: Tablets, Oral Solutions
3) By Application : Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications
Get an inside scoop of the montelukast sodium market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp
Regional Insights –
North America was the largest region in the montelukast sodium market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd
Table of Contents
1. Executive Summary
2. Montelukast Sodium Market Characteristics
3. Montelukast Sodium Market Trends And Strategies
4. Montelukast Sodium Market – Macro Economic Scenario
5. Global Montelukast Sodium Market Size and Growth
………….
32. Global Montelukast Sodium Market Competitive Benchmarking
33. Global Montelukast Sodium Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Montelukast Sodium Market
35. Montelukast Sodium Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
